Search results for Summary Safety Review
Filters
102 datasets for “Summary Safety Review”
- Open Government Canada
Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents
Health Canada | Santé CanadaUpdated 9 May 2024
… 18 years old (pediatric population), Health Canada did a review of this safety issue in this age group.
- HTML
- Open Government Canada
Summary Safety Review - DICLECTIN (doxylamine and pyridoxine combination) - Assessing Safety in pregnancy
Health Canada | Santé CanadaUpdated 8 May 2024
… The safety of Diclectin was recently reviewed by Health Canada as part of its routine health product monitoring …
- HTML
- Open Government Canada
Review Summary Report - Pre-licensing Review of NMWO’s Proposed Preliminary Safety Assessment Acceptance Criteria
Canadian Nuclear Safety Commission | Commission canadienne de sûreté nucléaireUpdated 2 Apr 2026
The NWMO requested Canadian Nuclear Safety Commission (CNSC) staff to conduct a pre-licensing technical review of its …
- Open Government Canada
Summary Safety Review - Propecia (finasteride 1 mg) and Proscar (finasteride 5 mg) - Assessing the Potential Risk of Seizures
Health Canada | Santé CanadaUpdated 10 May 2024
Health Canada carried out a safety review to look at the potential risk of seizures in patients taking …
- HTML
- Open Government Canada
Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury
Health Canada | Santé CanadaUpdated 10 May 2024
Health Canada reviewed the potential risk of liver injury with Pradaxa after receiving reports of severe liver injury …
- HTML
- Open Government Canada
Summary Safety Review - Celecoxib - Assessing the Risk of Serious Heart and Stroke Side Effects at High Doses Relative to Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Health Canada | Santé CanadaUpdated 8 May 2024
Health Canada carried out a safety review of all the available evidence to evaluate the risk of side …
- HTML
- Open Government Canada
Summary Safety Review - Green tea extract-containing natural health products - Assessing the potential risk of liver injury (hepatotoxicity)
Health Canada | Santé CanadaUpdated 9 May 2024
Health Canada reviewed the potential risk of liver injury with green tea extract-containing natural health products because …
- HTML
- Open Government Canada
Summary Safety Review - ABILIFY and ABILIFY MAINTENA (aripiprazole) - Evaluating the Risk of Certain Impulse Control Behaviours
Health Canada | Santé CanadaUpdated 8 May 2024
A safety review was conducted to evaluate the potential link between Abilify and Abilify Maintena (aripiprazole) and certain …
- HTML
- Open Government Canada
Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects
Health Canada | Santé CanadaUpdated 9 May 2024
Health Canada started a safety review following a review done by the FDA on systemic (taken by mouth …
- HTML
- Open Government Canada
Summary Safety Review - Over-the-Counter Products Containing Pseudoephedrine - Assessing the Potential Risk of Inflammation and Injury of the Large Intestine due to Insufficient Blood Supply (ischemic colitis)
Health Canada | Santé CanadaUpdated 10 May 2024
Summary Safety Review - Over-the-Counter Products Containing Pseudoephedrine - Assessing the Potential Risk of Inflammation and Injury of …
- HTML
- Open Government Canada
Summary Safety Review - Intraocular lenses - Assessing the potential risk of developing small pockets of liquid in intraocular lenses (glistening)
Health Canada | Santé CanadaUpdated 9 May 2024
… Health Canada has been actively monitoring reports of IOL glistening since 2012, with additional safety reviews completed in …
- HTML
- Open Government Canada
Summary Safety Review - Finasteride - Assessing the Potential Risk of Suicidal Thoughts and Behaviour (Suicidality)
Health Canada | Santé CanadaUpdated 9 May 2024
This safety review was carried out as a follow-up assessment on the potential risk of suicidality with …
- HTML
- Open Government Canada
Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]
Health Canada | Santé CanadaUpdated 10 May 2024
Health Canada reviewed the potential risk of a type of skin reaction known as subacute cutaneous lupus erythematosus …
- HTML
- Open Government Canada
Summary Safety Review - Hydroxyzine (ATARAX and generics) - Assessing the Potential Risk of Abnormal Heart Rhythm
Health Canada | Santé CanadaUpdated 9 May 2024
A safety review was undertaken soon after the European Medicines Agency notified Health Canada of the possibility that …
- HTML
- Open Government Canada
Summary Safety Review - Omnipod Insulin Management System - Assessing the potential risk of malfunctions with the device
Health Canada | Santé CanadaUpdated 9 May 2024
In 2014, Health Canada completed a first safety review for the Omnipod because a high number of complaints …
- HTML
- Open Government Canada
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
Health Canada | Santé CanadaUpdated 9 May 2024
Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a …
- HTML
- Open Government Canada
Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus
Health Canada | Santé CanadaUpdated 10 May 2024
Health Canada carried out a safety review to assess the risk of birth defects with the use of …
- HTML
- Open Government Canada
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Health Canada | Santé CanadaUpdated 8 May 2024
Health Canada carried out a safety review to look into the use of atypical antipsychotics and the potential …
- HTML
- Open Government Canada
Summary Safety Review - Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors INVOKANA (canagliflozin) and FORXIGA (dapagliflozin) - Evaluation of a Potential Risk of Acute Kidney Injury
Health Canada | Santé CanadaUpdated 10 May 2024
A safety review was done to evaluate the potential risk of acute kidney injury and the use of …
- HTML
- Open Government Canada
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Health Canada | Santé CanadaUpdated 8 May 2024
Health Canada carried out a safety review to look into the risk of sleep apnoea with the use …
- HTML